Finance

Beta
Lists
500124:BOM
Dr Reddy's Laboratories Ltd
₹1,276.75
+0.77%
(+9.70) 1D
Jun 5, 11:41:50 AM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 500124...
Open
₹1,279.95
High
₹1,280.70
Low
₹1,269.25
Mkt. cap
1.06T
Avg. vol.
108.41K
Volume
3.65K
Dividend
0.63%
Quarterly dividend
₹2.00
Ex-dividend date
Jul 10, 2026
P/E ratio
25.36
52-wk high
₹1,377.95
52-wk low
₹1,149.00
EPS
₹50.35
Shares outstanding
166.06M
No. of employees
28K
Open
₹1,279.95
High
₹1,280.70
Low
₹1,269.25
Mkt. cap
1.06T
Avg. vol.
108.41K
Volume
3.65K
Dividend
0.63%
Quarterly dividend
₹2.00
Ex-dividend date
Jul 10, 2026
P/E ratio
25.36
52-wk high
₹1,377.95
52-wk low
₹1,149.00
EPS
₹50.35
Shares outstanding
166.06M
No. of employees
28K
News stories
From sources across the web
Profile
Dr. Reddy's Laboratories Ltd. is an Indian multinational pharmaceutical company based in Hyderabad, with U.S. headquarters in East Brunswick, New Jersey. The company was founded by Kallam Anji Reddy, who previously worked in the mentor institute Indian Drugs and Pharmaceuticals Limited. Dr. Reddy manufactures and markets a wide range of pharmaceuticals in India and overseas. The company produces over 190 medications, 60 active pharmaceutical ingredients for drug manufacture, diagnostic kits, critical care, and biotechnology. Dr. Reddy's began as a supplier to Indian drug manufacturers, but it soon started exporting to less-regulated markets that had the advantage of not having to spend time and money on a manufacturing plant that would gain approval from a drug licensing body such as the U.S. Food and Drug Administration. By the early 1990s, the expanded scale and profitability from these unregulated markets enabled the company to begin focusing on getting approval from drug regulators for their formulations and bulk drug manufacturing plants – in more-developed economies. This allowed their movement into regulated markets such as the US and Europe. By 2007, Dr. Wikipedia
About Dr Reddy's Laboratories Ltd
CEOErez Israeli
Employees27.5K
Founded1984
HeadquartersHyderabad, Andhra Pradesh, India
SectorPharmaceutical industry
Websitedrreddys.com
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
85.45B
88.05B
87.27B
75.16B
Cost of goods sold
36.82B
39.91B
40.46B
41.47B
Cost of revenue
36.82B
39.91B
40.46B
41.47B
Research and development expenses
6.24B
6.20B
6.15B
5.46B
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
25.65B
26.44B
26.92B
27.76B
Operating expense
31.11B
31.90B
32.48B
32.53B
Total operating expenses
67.94B
71.81B
72.94B
74.00B
Operating income
17.52B
16.24B
14.33B
1.16B
Other non operating income
-
1.28B
570.00M
512.00M
EBT including unusual items
19.05B
18.35B
15.43B
1.99B
EBT excluding unusual items
18.36B
17.81B
15.52B
1.82B
Income tax expense
4.95B
4.08B
3.53B
-214.00M
Effective tax rate
25.99%
22.24%
22.90%
-10.75%
Other operating expenses
-779.00M
-740.00M
-591.00M
-693.00M
Net income
14.18B
14.37B
12.10B
2.20B
Net profit margin
16.59%
16.32%
13.86%
2.93%
Earnings per share
17.02
17.87
14.77
5.74
Interest and investment income
1.13B
912.00M
796.00M
890.00M
Interest expense
-830.00M
-907.00M
-944.00M
-1.06B
Net interest expenses
298.00M
5.00M
-148.00M
-167.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
22.28B
21.29B
19.54B
5.03B
Gain or loss from assets sale
40.00M
-308.00M
-179.00M
-2.10B
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer